Acknowledgements

#J* ST, | , Rome ( 8(cid:3)? (cid:15)/K(cid:30) MP rN FE SE, Immunogenetics « cco; of | f Longev- ity, SN ANN OO, coordinated | &(cid:21) Prof. ( IDI IIA®_Calogero ¢ a. —» Caruso, 1 to !5!5 oTand (cid:28)5(cid:29)5:(cid:30) (cid:3)? 1/K ) to ( !5!5 .and | (cid:28)5(cid:29)5 V—N. from} ———1 Ministry « of | f Health ane ty weeProjects ‘Immunological parameters BELLI IDES FOIE IISage-related’ and NN LLL LIL IDI ILIA ES‘Pharmacogenomics of SP OEEAlzheimer’s “oO eee eeDisease’, from the ELEMSicilian wr nee eeegovernment “Breast Cancer and my eeeImmune Response’ | me’ Gs"and | &(cid:21) al _ cooperation | contract | between | the aa pee eesDipartimento di oNBiopatologia  Metodologie Biome- —_hediche « BREEN EEN ME EE> dell’ Universita «  i di! i —i Palermo ) and t I the ] ——— om> Istituto | ) Nazio- nale > di Riposo « re ( > Cura per / ¢ Anziani ¢ idi/ i Ancona ( 1 (Longevity and oh Neeelderly | NIE EPdisability biological NN DEENmarkers). eEeeThis 3(cid:12)(cid:5)6 was also “Fee eeperformed yeeunder onaegis of AJ pe NIEprogramme “ae eetImAginE.

EINESSeveral omfindings point | out that gender is”   major variable 1 int \ the | wee pee» genetics « sof | ee REE Eef longevity, « ,and s | suggest « L as é  working ae EE GN eeehypothesis that aN eSmen i aerely ee OMEupon -oeeeeeeeeesgenetics more | ee E>- than od Pee| women | in | order | mtorr iiattain | x “Pee eo| longevity | | (Fran- ceschi et al., .///&:5 The present “oN hedata “sy eaeindicate instead | | that | “eee USthe NNN+874 | nt) aaa peIFN-y : allele | distribution | | is different in centenarian aN gp Meeewomen with respect to controls, but not in centenarian men. A"(cid:3)(cid:8) if the small —e——aroreenumber of male centenarians in the sample



Viticchi, !

(cid:

) Mattace, *

(cid:

) De Benedictis, )

(cid:

) Baggio, .///&

Do men and women follow different se OE “SOoes™trajectories reach ¢  | extreme | - longevity? | ’ Ttalian | | Multicenter | me

tudy « on | narians (

(cid:

)#J !A:

sw reese. Aging ( y (Milan) | ,.(cid:

) (cid:

)(cid:

)C(cid:

);

Goris, /  eye EE, Epplen, ¢ !

(cid:

) “fe # kee, Fiten, F >

(cid:

) Ne EE, Andersson, } #

(cid:

) , Murru, | *

(cid:

) ’

(cid:

)

(cid:

) as Pree, Ronsse, | LJ , Jackel, §

(cid:

) » Epplen, J -

(cid:

)

(cid:

) , Marrosu, } #

)

(cid:

)  , Grimaldi, I (cid:

)

#

(cid:

) woe es SP eee, Opdenakker, ¢ )

(cid:

) , Billiau, / A. N

(cid:

) ,;;;

. Analysis or meeef an |

IFN-y § / gene (

(cid:

)’

): ) polymorphism i multiple :  SEE OEsclerosis i sin | | Europe: «

effect « me Ne| of

] ee EE Pee

population Oe eee| structure | TEE Eeassociation \

with ¢

disease. J -

Pee ene. Interferon ( Pee

Cytokine | *(cid:

)(cid:

)

,;(cid:

) ,/(cid:

)

Grimaldi, | (cid:

)

#

(cid:

) , Casadei, ' O

#

(cid:

) . Ferri, | !

(cid:

) . Veglia, | ’

(cid:

) . Licastro, | Annoni, | )

(cid:

)  Biunno, |

,  : Bellis, | )

(cid:

) Ene:Sorbi, |

(cid:

) _ Mariani, | Canal, |

(cid:

) _ Griffin,

(cid:

) . Franceschi, | #

(cid:

) .///

. Association early-onset Alzheimer’s | _ disease with | an interleukin-la | EF III IIDpolymorphism. . Ann. | . Neurol. ¢

, :  <

,C<

=

pe?Harris, “ (cid:

)

$

(cid:

) ee Oe EE, Ferrucci, |   , Tracy, | *

>

(cid:

) , Corti, } #

!

(cid:

) , Wacholder J

(cid:

) "Ettinger, '

@

(cid:

) Ry EMO ZANE Heimovitz, | @

(cid:

) Cohen, @

-

(cid:

) Wallace, | ,;;;

ETI EE EENAssociations of elevated  interleukin-

and protein | \ levels

; with

) mortality i int \ the « » elderly. . Am... -

#(cid:

)(cid:

)

=/

C=,<

Hobson, | A

A

(cid:

) _ Ralston, |

@

(cid:

) .//,

_ Role « Of | ' genetic | - factors | in t pathophysiology < y and

| management ¢ t of « OE EEN I IIEf osteoporosis.  . Clin. I reneecrinol. (

(?(cid:

)(cid:

)(cid:

)(cid:

): )

, | ,C;

ER IENEE XSM

usker, |

#

(cid:

) MEDCurran,  #

(cid:

)

(cid:

) Dynan, N

$

(cid:

) M

ullagh, | Urquhart, | _D.D., | . Middleton, |  EEE EAE, Patterson, | !

!

(cid:

) —, Mcllroy, | ee

assmore, . (cid:

)

>

(cid:

) .//,

Association | . between | ey EE ET EE| polymorphism | regulatory

region | of | "gene | - encoding

ee |tumour | © pes sees bis  i| factor | coand OODrisk Jof “oe BNAlzheimer’s disease om weeand vascular dementia: case-control : | study. | . Lancet ‘ <=(cid:

)(cid:

) (cid:

)<

C(cid:

)(cid:

)/

Pawelec, ‘ )

(cid:

) _ Effros, | *

$

(cid:

) Caruso, | !

(cid:

) , Remarque, | A

(cid:

) , Barnett, Solana, | *

(cid:

) ,;;;

‘cells ; and | aging. | A_ Front. | _ Biosci. :

,

(cid:

).

;

Pravica, O

(cid:

) _ Asderakis,  _Perrey, | !

(cid:

) | Hajeer,  Sinnott, | Hutchinson, | (cid:

)

O

(cid:

) ,;;;

In) ye ID

vitro | es ee bn) production «

of | f IFN-y « with ( !(cid:

) \ repeat J t polymorphism i

the | > human |

IFN-y § “

y gene. I A(cid:

)(cid:

)

EEImmunogenet.

.

(cid:

) ,C<

Pravica, | O

(cid:

) Ee_ Perrey, | !

(cid:

) Stevens, .   -

@

(cid:

) Hutchinson, | .///

= MEE SD_ single

J?

moe- nucleotide |  » polymorphism i in { the | + first i  | intron ¢ the | > human | oe

IFN-y § y gene: d ee pee Fe: absolute NS

”> correlation \

with

lary !(cid:

) EI IIE IE SES. microsatellite

oe ees> marker ¢ r of | f high |

IFN-y § ) gene. | @(cid:

)(cid:

)

,(cid:

) (cid:

)

<C(cid:

)

Solerte,

$

(cid:

) , Cravello, |  , Ferrari, | A

(cid:

) , Fioravanti, | #

(cid:

) .///

production ¢

of I f IFN-y a y and

TNF-a f . from r

natural k I killer (

N: ) cells i —_—eeassociated \ | with < Aes pe

abnormal |

N reactivity < y and « nna’ Nae™| cognitive ¢ ment | in . | Alzheimer’s « » disease.

_ Ann. |

L << SAcad. | Sci. | ;,(cid:

)(cid:

) <(cid:

)/

Verthelyi, |  , Klinman, | (cid:

)

#

(cid:

) .///

(cid:

)? ‘ hormone | - levels IEDwith

Jo“

the ¢   of « F cytokine-secreting « cells i in} "(cid:

)"(cid:

)

ogy | ,//(cid:

) <(cid:

)(cid:

)C<;/

Awad, } #

(cid:

) , Pravica, \ O

(cid:

) , Perrey, ¢ !

(cid:

) A(cid:

)

Gamel, /  , Yonan, }